statistiche ricercatore

ACCOLLA, ROBERTO

Distribuzione geografica

Continente	#
NA - Nord America	28.595
EU - Europa	16.533
AS - Asia	10.066
SA - Sud America	1.079
Continente sconosciuto - Info sul continente non disponibili	235
AF - Africa	154
OC - Oceania	26
Totale	56.688

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	28.027
IT - Italia	7.952
SG - Singapore	3.181
UA - Ucraina	2.756
CN - Cina	2.261
VN - Vietnam	1.519
TR - Turchia	1.424
DE - Germania	1.293
SE - Svezia	1.083
HK - Hong Kong	1.066
BR - Brasile	929
FI - Finlandia	747
IE - Irlanda	667
FR - Francia	611
GB - Regno Unito	561
RU - Federazione Russa	484
CA - Canada	326
IN - India	190
MX - Messico	118
BD - Bangladesh	92
PL - Polonia	82
JP - Giappone	79
NL - Olanda	63
AR - Argentina	56
BE - Belgio	50
ES - Italia	50
NG - Nigeria	44
ZA - Sudafrica	44
IQ - Iraq	39
PK - Pakistan	37
LT - Lituania	27
AT - Austria	21
JM - Giamaica	20
AU - Australia	19
CR - Costa Rica	18
EC - Ecuador	18
VE - Venezuela	18
AE - Emirati Arabi Uniti	17
CO - Colombia	17
KR - Corea	17
SA - Arabia Saudita	17
MA - Marocco	16
PY - Paraguay	15
SV - El Salvador	15
CZ - Repubblica Ceca	14
PH - Filippine	14
MY - Malesia	13
NI - Nicaragua	13
CH - Svizzera	12
EU - Europa	12
GT - Guatemala	12
HN - Honduras	12
KE - Kenya	12
TT - Trinidad e Tobago	12
ID - Indonesia	11
JO - Giordania	10
UZ - Uzbekistan	10
CL - Cile	9
DZ - Algeria	9
NP - Nepal	9
PE - Perù	9
EG - Egitto	8
IR - Iran	8
TN - Tunisia	8
BY - Bielorussia	6
CW - ???statistics.table.value.countryCode.CW???	6
DO - Repubblica Dominicana	6
MD - Moldavia	6
NZ - Nuova Zelanda	6
TW - Taiwan	6
DK - Danimarca	5
GE - Georgia	5
LB - Libano	5
PR - Porto Rico	5
PS - Palestinian Territory	5
RS - Serbia	5
IL - Israele	4
KH - Cambogia	4
RO - Romania	4
AL - Albania	3
BG - Bulgaria	3
BH - Bahrain	3
CI - Costa d'Avorio	3
EE - Estonia	3
GP - Guadalupe	3
GR - Grecia	3
GY - Guiana	3
HR - Croazia	3
KZ - Kazakistan	3
LU - Lussemburgo	3
MT - Malta	3
OM - Oman	3
PA - Panama	3
PT - Portogallo	3
AZ - Azerbaigian	2
BB - Barbados	2
BN - Brunei Darussalam	2
BO - Bolivia	2
ET - Etiopia	2
GA - Gabon	2
Totale	56.438

Salva come PNG Salva come JPEG

Città	#
Milan	5.743
Ashburn	2.876
San Jose	2.285
Fairfield	2.139
Jacksonville	2.115
Woodbridge	1.749
Singapore	1.728
Chandler	1.580
Ann Arbor	1.181
Houston	1.181
Council Bluffs	1.061
Hong Kong	1.047
Seattle	919
Wilmington	914
Dallas	847
Izmir	764
Princeton	717
Dearborn	698
Cambridge	695
Dublin	662
Beijing	609
Nyköping	541
Rome	437
Boardman	432
Dong Ket	430
The Dalles	417
Lauterbourg	315
Chicago	295
New York	280
San Mateo	242
Los Angeles	241
Como	238
Ho Chi Minh City	202
Santa Clara	194
San Diego	170
São Paulo	169
Toronto	154
Orem	145
Ogden	141
Hanoi	137
Helsinki	136
Guangzhou	117
Munich	95
London	92
Düsseldorf	83
Tokyo	76
Verona	74
Mexico City	71
Chennai	70
Warsaw	68
Hefei	64
Buffalo	57
Shanghai	56
Brooklyn	54
Montreal	53
Frankfurt am Main	51
Manchester	51
Kunming	49
Nanjing	49
Brussels	45
Phoenix	45
Norwalk	43
Abuja	42
Atlanta	40
Denver	40
Hangzhou	40
Amsterdam	39
Jinan	38
Boston	37
Turku	36
Washington	36
Pune	34
Da Nang	33
Naples	32
Stockholm	32
Johannesburg	31
San Francisco	31
Shenzhen	31
Haiphong	29
Kocaeli	29
Fuzhou	28
Memphis	28
Mumbai	28
Tianjin	26
Poplar	25
Charlotte	20
Miami	20
Redwood City	20
Wuhan	20
Zhengzhou	20
Columbus	19
Las Vegas	19
Philadelphia	19
Belo Horizonte	18
Falls Church	18
Nuremberg	18
Rio de Janeiro	18
St Petersburg	18
Changsha	17
Berlin	16
Totale	39.234

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	283
Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response	279
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	263
Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines	252
Unsung hero Robert C. Gallo	247
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line	245
Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens	245
Antibody-mediated activation of a deletion-mutant b-galactosidase defective in the a-region	245
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches	245
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	244
Investigating Human T Cell Lymphotropic Retrovirus (HTLV) tax function with molecular and immunophenotypic techniques	244
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	244
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients	241
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	240
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	240
Functional significance of polymorphism among MHC class II gene promoters	239
Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma	233
Demonstration at the single cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets	232
Human adipose-derived stem cells promote vascularization of collagen-based scaffolds transplanted into nude mice	231
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	225
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	225
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	225
An enhancer factor defect in a mutant Burkitt lymphoma cell line	224
aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.	221
Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.	221
Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy	220
Allogeneic mixed lymphocyte reactions in humans : Pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation	220
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	220
The MHC class II transactivator: prey and hunter in infectious diseases	219
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	218
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	218
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	218
Treg function as a marker to define the susceptibility to T1DM clinical onset in a healthy subject with antibodies positivity?	216
Transcriptional regulation of MHC class II genes	216
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	215
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	214
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	214
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	213
Host defense mechanisms against pathogens	213
Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen "CEA".	212
Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb	212
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	212
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	212
Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids	211
H2-RESTRICTED RECOGNITION OF CLONED HLA CLASS-I GENE-PRODUCTS EXPRESSED IN MOUSE CELLS	211
Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family	210
In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator	210
Divergent evolution in the mechanisms controlling major histocompatibility complex class II gene transcription in mouse and human	210
The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets	209
Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation	209
Autoimmunità e Malattie Autoimmuni	207
Detection of human chromosomes in somatic cell hybrids by PCR analysis	206
APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis	205
CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: Toward the construction of an optimal anti-tumor vaccine	205
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells	204
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	203
Biochemical aspects of human Ia molecules	203
Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody	202
Monoclonal antibodies against carcinoembryonic antigen (CEA) used in solid-phase enzyme immunoassay	202
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	202
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.	201
Analisi dell’espressione genica in cellule epiteliali umane trattate con la proteina Tat di HIV	201
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	201
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	200
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	198
Enterovirus infection and low Treg function: two possible biomarkers of progression to autoimmune T1D.	198
Distinct forms of both a and b subunits are present in the human Ia molecular pool	197
IL-2 mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.	196
SUSCEPTIBILITY OF HUMAN-MOUSE T-CELL HYBRIDS TO HIV-PRODUCTIVE INFECTION	196
Subsets of human Ia-like molecules defined by monoclonal antibodies	195
Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes.	194
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.	193
Analysis of the antigen specific T cell repertoire in HIV infection	193
Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines.	192
Reducing the global burden of HTLV-1 infection: An agenda for research and action	192
Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors.	191
Somatic cell hybrids producing antibodies specific to human fibronectin.	191
Stable integration of mouse DNA into Ia-negative human B-lymphoma cells causes reexpression of the human Ia-positive phenotype.	191
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	191
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	190
Apparente dissociazione tra fenotipo DR e genotipo MHC di classe II in IDDM	189
THE HUMAN IA-ASSOCIATED INVARIANT CHAIN IS SYNTHESIZED IN IA-NEGATIVE B-CELL VARIANTS AND IS NOT EXPRESSED ON THE CELL-SURFACE OF BOTH IA-NEGATIVE AND IA-POSITIVE PARENTAL CELLS	189
Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.	188
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen	188
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	187
New strategies of mammary cancer vaccination	187
Superinfection by Epstein-Barr virus of a subset of Raji cells is independent of HLA class-II antigens	187
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	186
ras-Family gene mutations in neoplasia of the ampulla of Vater	185
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	185
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	184
Tripartite motif 22 and class II transactivator restriction factors: Unveiling their concerted action against retroviruses	184
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	183
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	182
A dual defensive role of CIITA against retroviral infections	182
Htlv-1 infection and pathogenesis: New insights from cellular and animal models	182
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	181
Interspecies somatic T cell hybrids as biological tools for studying gene expression during T cell development	179
Isolation of cDNA clones encoding HLA-DR a chains	178
Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.	178
Totale	21.009

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	216.720
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	216.720

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2.152	0	0	0	231	114	95	124	219	150	468	278	473
2022/2023	4.358	470	150	270	468	343	947	6	640	633	135	167	129
2023/2024	8.694	1.434	1.405	1.535	1.536	1.645	542	64	110	272	44	18	89
2024/2025	4.898	53	74	928	149	222	235	218	321	563	300	402	1.433
2025/2026	11.774	763	658	542	1.610	1.087	799	2.785	742	1.262	728	508	290
2026/2027	4.225	264	566	1.858	1.537	0	0	0	0	0	0	0	0
Totale													56.688